Clinical Trial

(Image: Getty/masterzphotois)

How to reduce the odds of failure in late phase clinical trials

By Melissa Fassbender

Improving the prognostic value of early phase data is among one of several ways to increase the probability of successes in drug development, a process which has become more expensive as failure rates have risen, says an industry expert.

(Image: Getty/Ipopba)

Envigo paves new first-in-human trial solution

By Maggie Lynch

The non-clinical contract research services and research model provider Envigo launches a new solution it says optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.

(Image: Getty/solarseven)

Novartis joins longitudinal study for RWD

By Maggie Lynch

Novartis Pharma AG partners with Target PharmaSolutions to support its global longitudinal observational study designed to generate real-world clinical data.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All